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Abstract
Background: Cognition is a multidimensional construct and to our knowledge, no previous studies have examined 
the independent contribution of specific domains of cognition to health related quality of life. To determine whether 
executive functions are independently associated with health related quality of life assessed using Quality Adjusted Life 
Years (QALYs) calculated from the EuroQol EQ-5D (EQ-5D) in older women after adjusting for known covariates, 
including global cognition. Therefore, we conducted a secondary analysis of community-dwelling older women aged 
65-75 years who participated in a 12-month randomized controlled trial of resistance training. We assessed global 
cognition using the Mini-Mental State Examination (MMSE) and executive functions using the: 1) Stroop Test; 2) Trail 
Making Test (Part B) and 3) Digits Verbal Span Backwards Test. We calculated QALYs from the EQ-5D administered at 
baseline, 6 months and 12 months.
Results: Our multivariate linear regression model demonstrated the specific executive processes of set shifting and 
working memory, as measured by Trail Making Test (Part B) and Digits Verbal Span Backward Test (p < 0.01) 
respectively, were independently associated with QALYs after accounting for age, comorbidities, general mobility, and 
global cognition. The final model explained 50% of the variation in QALYs.
Conclusions: Our study highlights the specific executive processes of set shifting and working memory were 
independently associated with QALYs -- a measure of health related quality of life. Given that executive functions 
explain variability in QALYs, clinicians may need to consider assessing executive functions when measuring health 
related quality of life. Further, the EQ-5D may be used to track changes in health status over time and serve as a 
screening tool for clinicians.
Trial Registration: ClinicalTrials.gov Identifier: NCT00426881.
Background
Health related quality of life (HRQL) is an important con-
struct that describes an individual's overall health status.
I t  i s  c o m m o n l y  u s e d  i n  e c o n o m i c  e v a l u a t i o n s  [ 1 ]  a s  a
measure of health benefit, and may be more responsive
among populations with conditions associated with high
morbidity [2]. HRQL is defined by several domains [3],
with general agreement that emotion, physical and social
are core domains. These concur with WHO's definition
of health - a state of complete physical, mental, and social
well-being, and not merely the absence of disease or infir-
mity [4]. However, the specific contribution of HRQL to
quality of life remains unknown [5] given HRQL is "the
subjective assessment of the impact of disease and treat-
ment across the physical, psychological, social, and
somatic domains of functioning and well-being [6]."
The use of a generic, preference-based instrument is
one method commonly used to assess HRQL [7]. The
EQ-5D is one example of such a generic preference based
utility instrument developed by the EuroQol Group [8].
The EQ-5D captures 243 unique health states and cap-
tures the following domains using a short five-item ques-
tionnaire: 1) mobility, 2) self-care, 3) usual activities, 4)
pain and 5) anxiety/depression [8]. Individuals' prefer-
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ences for the scoring of the EQ-5D were estimated using
the time trade off technique on a random sample of
adults taken from the population living in the York (UK)
region (N = 3000) [9]. The EQ-5D is the most widely used
generic instrument that uses a utility-based scoring
approach, yielding a single summary score on a common
scale to facilitate comparison across different health con-
ditions and patient populations [10,11]. The single sum-
mary score, defined as a health state utility value (HSUV)
is anchored at zero - a health state equivalent to death
and 1.0 - a state of "full health." HSUVs less than zero are
defines health states worse than death.
HSUVs are used to calculate Quality Adjusted Life
Years (QALYs) to account for the quality of life of a
patient (measured using health utilities from a generic
preference based utility instrument such as the EQ-5D) in
a given health state and the time spent in that health
state. Briefly, the QALY is a useful measure of health ben-
efit because it simultaneously captures both quantity and
quality gains or losses [12]. A key benefit of the QALY is
that it enables direct comparison of patient outcomes
across diseases and diverse health interventions [12].
Also, it accounts for changes in both morbidity and mor-
tality under a common metric. QALYs are defined as a
measure of health benefit in terms of time spent in a
series of quality-weighted health states, in which the
quality weights reflect the desirability of living in the
state, typically anchored at "perfect" health (weighted 1.0)
to dead (weighted 0.0)" [13]. The quality weights spent in
each state are multiplied by the time spent in each state.
The sum of all these products is the total number of
QALYs. QALYs are one measure used to assess HRQL.
Clinical measures that are associated with HRQL
include cognition, physical disability and chronic condi-
tions such as rheumatoid arthritis, sex, social functioning
and physical activity [14]. Specifically, two studies dem-
onstrated that adults with a physical disability, asthma or
who are female had significantly increased odd ratios for
poor HRQL [15,16]. Among individuals with Alzheimer's
disease, global cognition as measured by the Mini Mental
State Examination (MMSE), was associated with HSUVs
measured by the EQ-5D [17].
Cognition is a multidimensional construct and to our
knowledge, no previous studies have examined the inde-
pendent contribution of specific domains of cognition to
HRQL. We hypothesize that executive functions may be
of particular importance to HRQL. Executive functions
are higher-order cognitive processes that control plan-
ning, initiation, sequencing and monitoring of complex
goal directed behavior [18,19]. These cognitive processes
are essential to the person's ability to carry out health-
promoting behaviours [20], such as medication manage-
ment, dietary and lifestyle changes, self-monitoring of
responses, and follow-up with health care professionals.
H e n c e ,  i n  t h i s  s t u d y ,  w e  e x a m i n e d  w h e t h e r  e x e c u t i v e
functions are independently associated with HRQL in
community-dwelling older women, calculated using the
EQ-5D HSUVs at three time points, after accounting for
global cognitive function and known covariates.
Methods
Study Design and Participants
The total sample for this analysis consisted of 135 women
who consented and completed a randomized controlled
trial of exercise (NCT00426881; Brain Power study) that
aimed to examine the effect of once-weekly and twice-
weekly resistance training on cognitive performance of
executive functions. The design and the primary results
of the Brain Power study have been reported elsewhere
[21]. Briefly, participants enrolled in Brain Power were:
aged 65 to 75 years, community-dwelling, and had a
MMSE ≥ 24.
Functional Comorbidity Index
Functional Comorbidity Index was calculated to estimate
the degree of comorbidity associated with physical func-
tioning [22]. This scale's score is the total number of
comorbidities.
Global Cognition Measures - Mini Mental State 
Examination
The MMSE is a widely used and well-known question-
naire used to screen for cognitive impairment (i.e.,
MMSE <24) [23]. It is scored on a 30-point scale with a
median score of 28 for more normal octogenarians with
more than 12 years of education [23]. The MMSE may
underestimate cognitive impairment for frontal system
disorders [24] because it has no items specifically
addressing cognitive function [23].
Central Executive Functions--Set Shifting, Updating and 
Response Inhibition
Our assessment of executive functions were composed of
three tests that measure different aspects of executive
functions: [18] 1) Trail Making Test Part B, 2) Verbal Dig-
its Backward Test and 3) Stroop Colour-Word Test.
Trail Making Part B
We used the Trail Making Part B test to assess set shift-
ing. Set shifting refers to an individuals ability to go back
and forth between multiple tasks or mental sets [25]. The
test consists of one page with circled letters (A-L) and
numbers (1-13). We instructed participants to draw a sin-
gle line as quickly and accurately as possible from 1 to A,
A to 2, 2 to B and so forth until the task was completed.
We recorded the number of errors and the length of time
the task took. To index set shifting, we calculated the dif-
ference between Part B and Part A completion time.
Smaller difference scores indicate more cognitive flexibil-Davis et al. BMC Geriatrics 2010, 10:16
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ity. Reliability scores for the Trail Making Part B varied
from moderate to excellent [26].
Verbal Digits Backward
We used the Verbal Digits Backward test to assess work-
ing memory [27]. Working memory (updating) refers to
an individuals ability filter incoming information for rele-
vance to the current task and subsequently update infor-
mational content replacing old non-relevant information
with new relevant incoming information [25]. Seven pairs
o f  r a n d o m  n u m b e r  s e q u e n c e s  w e r e  r e a d  a l o u d  b y  a n
assessor at one number per second. The first sequence of
numbers is three and the sequence was increased by one
number up to a length of nine digits. Participants
repeated each sequence in exactly the reverse order until
they failed two attempts of the same sequence length. It
was scored on a 14-point scale with higher scores indicat-
ing a better performance. For the verbal digits forward
test, the participant's task is to repeat each sequence
exactly as it is given. The difference between the verbal
digits forward test score and the verbal digits backward
test score was used as an index of the central executive
component of working memory. Smaller difference
scores indicate better working memory.
Stroop Test
The Stroop Test, assessed response inhibition [28]
including deliberate inhibition of automatic, dominant or
routine responses [26]. For the primary test condition,
participants were presented colour-words printed in
incongruent coloured inks (e.g., the word "BLUE" printed
in red ink) and were required name the ink colour that
the words were printed while ignoring the word itself. We
recorded the time participants took to read each condi-
tion. The ability to selectively attend and control response
output was calculated as the time difference between the
test condition and the priming condition (e.g., coloured
X's). Smaller time differences indicate better selective
attention and conflict resolution.
Preference Based Measures - HSUV Instrument
The HSUV instrument we used was the EQ-5D. Major
differences between the EQ-5D and other preference
based measures were outlined previously [8]. The EQ-5D
does not directly measure cognition; another generic
preference based instrument, the Health Utilities Index
Mark 3 (HUI3) does [29]. To our knowledge, no previous
studies have examined the association between executive
functions and HRQL using the HUI3. Therefore, we
chose the EQ-5D given that is it the most widely used
generic preference based utility instrument that has been
used among individuals with cognitive decline.
The EQ-5D is a short five item generic HSUV instru-
ment designed to assess HRQL [30]. The EQ-5D short
structure was considered a strength in terms of high
response rates, participant burden and feasibility [31] and
a weakness in terms of its responsiveness and sensitivity
[32]. The EQ-5D is used for cross-national comparisons
of health status [33] and captures 243 unique health states
[8]. We used the EQ-5D to calculate QALYs as an assess-
ment of an individual's HRQL according to the following
five EQ-5D domains: mobility, self-care, usual activities,
pain, and anxiety/depression. Each domain has three pos-
sible options that either indicates no problems, some
problems or severe problems. The EQ-5D HSUVs at each
time point are bounded from -0.54 to 1.00 where a score
of less than zero is indicative of a health state worse than
death. We used three HSUVs for each individual from the
EQ-5D at baseline, 6 months and 12 months to calculate
QALYs for each individual. Specific to this study only,
QALYs are a measure of HRQL because zero participants
died and all participants were followed for the same time
period, thus any changes in QALYs are due to quality of
life, rather than quantity of time spent in a given health
state.
Timed Up and Go
We used the Timed Up and Go Test (TUG) to assess gen-
eral mobility [34]. Participants were instructed to rise
from a chair with their arms crossed (seat height 45 cm),
walk a distance of three meters, turn around, walk back to
the chair, and sit down with their arms crossed around
their chest. We timed each trial and took the mean of two
trials for our statistical analysis.
Data Analysis
We analysed all data using STATA version 10.0. Our base
case analysis included 135 women based on recommen-
dations for multiple imputation of missing cost and
HSUV data [35]. For all discrete time points, we used a
combination of multiple imputation and bootstrapping to
estimate uncertainty caused by missing values and we
report both the imputed data set analysis and a complete
case analysis. Our complete case analysis consisted of 89
participants for the EQ-5D who had all three HSUVs at
baseline, 6-months and 12-months.
We report descriptive data for all variables of interest.
For data that are normally distributed we report mean
and standard deviation and frequencies depending on the
m e a s u r e .  F o r  d a t a  t h a t  w e r e  s i g n i f i c a n t l y  s k e w e d ,  w e
report median and interquartile range. We used the Pear-
son product moment correlation coefficient to determine
the level of association between QALYs and age, group,
education, average waist girth, functional comorbidity
index, general mobility, global cognition and executive
functions.
I n  o u r  m u l t i p l e  l i n e a r  r e g r e s s i o n  m o d e l ,  a g e ,  g r o u p ,
education, average waist girth, functional comorbidity
index, general mobility and global cognition were statisti-
cally controlled by forcing these six variables into theDavis et al. BMC Geriatrics 2010, 10:16
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regression model first (Model 1). These independent
variables were determined based on the results of the
Pearson product moment coefficient analyses (i.e., alpha
level ≤ 0.05) and assumed biological relevance, such as
MMSE and waist girth were entered into the model
regardless of the results of the correlation analyses. Each
of the executive functions (i.e., Trail Making Part B, Dig-
its Backwards, Stroop Colour Word) was then entered
sequentially into the model. Those that significantly
added to the model (i.e., significant change in R2) were
kept in the model. Digits Backward was entered last into
the model. We assessed the assumptions of normality of
the residuals and heteroscedasticity.
Results
We report the results of both the imputed case analysis
and the complete case analysis. For the complete case
analysis, we calculated QALYs from the EQ-5D for 89 of
the 135 participants.
Sample
Table 1 reports descriptive statistics for descriptive vari-
ables (age, baseline EQ-5D HSUV, group, education,
average waist girth, functional comorbidity index, trail
m a k i n g  p a r t  A ,  t r a i l  m a k i n g  p a r t  B ,  D i g i t s  F o r w a r d ,
MMSE and TUG) and our outcome of interest (QALYs).
Participants included in our imputed and case analysis
were similar on demographic characteristics. Overall, this
cohort of community-dwelling senior women were high
functioning individuals as indicated by their baseline EQ-
5D HSUVs of 0.82 (SD: 0.19) and 0.85 (SD: 0.18) for the
imputed and complete case sets, respectively. Further, the
mean MMSE was greater than 28 (max 30 points).
Correlation Coefficients
Table 2 reports the correlation coefficients between vari-
ables of interest and QALYs. Age, education, baseline EQ-
5D HSUV, average waist girth, functional comorbidity
index, TUG, set shifting (assessed by the difference score
for Trail Making Part B and A) and working memory
(assessed by the difference score for Digits Forward and
Backward) were significantly associated with QALYs cal-
culated from the EQ-5D (p < 0.05). Group and response
inhibition (assessed by using the Stroop Colour-Word
test) were not significantly associated with QALYs calcu-
lated from the EQ-5D (p > 0.05).
Multivariate Linear Regression Results for QALYs calculated 
from the EQ-5D
The Trail Making Part B was a significant and indepen-
dent predictor for HRQL as assessed by the EQ-5D (p <
0.01). Digits Backward was also a significant predictor for
HRQL based on the EQ-5D (p < 0.01) based on the
results of the imputed data set (for complete case set, p =
0.09). Adding the Trail Making Part B and the Digits
Backward resulted in an R2 change of 4% (p < 0.01). The
total variance accounted for by our final model was 50%
(Table 3). The R2 and R2 change from both imputed and
complete case analysis were identical to 1/100 decimal.
The Stroop Colour-Word task did not significantly
improved the model after accounting for age, group, edu-
Table 1: Characteristics of the Brain Power cohort at baseline (N = 89)
Variable at Baseline Imputed Data Set Complete Case Set
Mean Standard Deviation Mean Standard Deviation
QALY (EQ-5D) 0.83 0.17 0.83 0.17
Age (years) 69.6 3.0 69.7 3.0
Baseline EQ-5D HSUV 0.82 0.19 0.85 0.18
Average waist girth (cm) 86.3 13.0 87.3 12.4
Function Comorbidity Index 2.1 1.7 2.0 1.6
Trail A (sec) 55.3 18.3 54.4 17.7
Trail B (sec) 101.2 41.7 97.0 36.7
Trail B - Trail A 42.5 29.9 46.2 34.8
Digits Forward (max 14 pts) 7.9 2.3 7.9 2.3
Digits Backward (max 14 pts) 4.5 2.4 4.3 2.4
Digits Forward - Digits Backward 3.7 2.3 3.4 2.3
MMSE (max 30 pts) 28.6 1.3 28.7 1.4
Timed Up and Go Test (sec) 6.6 1.4 6.7 1.5Davis et al. BMC Geriatrics 2010, 10:16
http://www.biomedcentral.com/1471-2318/10/16
Page 5 of 8
cation waist girth, functional comorbidity index, general
mobility and global cognition.
Discussion
Relationship between executive functions and QALYs - 
HRQL
Persons who experience cognitive decline have a reduced
quality of life [36]. To our knowledge, our study is the first
to demonstrate the independent association between key
executive processes as measured by standard neuropsy-
chological tests, and QALYs measured prospectively over
one year among high functioning community-dwelling
senior women. Of particular importance, this indepen-
dent association was found in this cohort of senior
women after accounting for age, waist girth, functional
comorbidity index, general mobility and global cognition.
Also, our final model explained 50% of the variation in
QALYs; regression models in clinical research often do
not account for such a large amount of variance [37].
We specifically found that, both set shifting and work-
ing memory, were independently associated HRQL, mea-
sured by QALYs calculated from the EQ-5D HSUVs. Our
novel result extends previous findings that set shifting, as
the Trail Making B Test, is associated with factors that
may influence QALYs: 1) mobility [38,39]; 2); medication
adherence [40]; 3) driving performance [41]; 4) anxiety
and emotional regulation [42]. We highlight that mobility
and anxiety/depression are domains in the EQ-5D. Addi-
tionally, our current finding also extends previous find-
ings that working memory is associated with pain
severity; pain is one of the five domains of the EQ-5D;
therefore, we would expect an association with QALYs
[43].
We acknowledge that executive functions are only one
aspect of cognition and were the sole cognitive processes
explored in the Brain POWER study [21]. The Brain
POWER study focused specifically on executive func-
tions because these cognitive processes: 1) decline sub-
stantially with aging [44]; 2) are associated with the ability
to carry out health-promoting behaviours [45]; and 3) are
most responsive to exercise training [46]. Because execu-
Table 2: Correlation coefficient matrix‡
Variable at Baseline Imputed Data Set
QALYs (EQ-5D)
Age -0.298**
Group 0.0913
Education 0.3106**
Average waist girth -0.232*
Function Comorbidity Index -0.488**
Trail B - Trail A -0.1084*
Digits Forward - Digits Backward -0.1710**
MMSE 0.051
Timed Up and Go -0.598**
Stroop -0.113
‡ Results from both imputed and complete case analysis were 
identical to 0.000 decimal.
* p < 0.05
** p < 0.01
Table 3: Bivariate and Multiple Linear Regression Summary for QALYs in Older Women Calculated from EQ-5D HSUVs‡
Imputed Data Set Complete Case Set
Independent Variables Unstandardized ß 
(Standard Error)
P-value Unstandardized ß 
(Standard Error)
P-value
Model R2 0.536 R2 0.536
Trail B - Trail A 0.0012 (0.0002) 0.00** 0.0012 (0.0005) 0.031*
Digits Forward -Digit Backward -0.011 (0.003) 0.00** -0.011 (0.007) 0.084
Age 0.0008 (0.0022) 0.717 0.0008 (0.0052) 0.88
Group -0.008 (0.008) 0.296 -0.008 (0.018) 0.66
Education 0.025 (0.005) 0.00** 0.02 (0.01) 0.024*
Average waist girth -0.0006 (0.0005) 0.240 -0.0006 (0.0012) 0.62
Functional Comorbidity Index -0.036 (0.004) 0.00** -0.036 (0.009) 0.00**
Timed Up and Go -0.062 (0.005) 0.00** -0.06 (0.01) 0.00**
MMSE -0.017 (0.005) 0.001 -0.02 (0.01) 0.15
‡ R2 and R2 change were the same for both imputed and complete case analysis
* p < 0.05
** p < 0.01Davis et al. BMC Geriatrics 2010, 10:16
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tive functions are associated with the ability to carry out
health-promoting behaviours [45], we hypothesized that
reduced executive functioning may directly impact the
overall health status of older adults. However, we
acknowledge that other cognitive domains may also influ-
ence health status. Hence, future studies are needed to
explore the contribution of other cognitive domains to
health status in older adults.
Establishing a relationship between working memory and 
health related quality of life
Our finding of both set shifting and working memory
contributing to health related quality of life concur and
extend previous studies examining the association of cog-
nitive function and instrumental activities of daily living.
Instrumental activities of daily living include the ability to
prepare a balanced meal, remember appointments, keep
financial records and take medications as prescribed [47].
Health related quality of life is related to one's ability to
perform instrumental activities of daily living [48] and
one's overall mobility [49] Previous studies have demon-
strated that executive functions are associated with
instrumental activities of daily living and functional sta-
tus among older adults [50,51]. Specifically, the Trail
Making B Test is an independent predictor of the instru-
mental activities of daily living [50,51].
Response inhibition and health related quality of life - 
comparison with another study
Our findings for the Stroop test and health related quality
of life differ from those of previous research [52]. Specifi-
cally, one study conducted among 72 older adults with
stable cardiovascular disease found a significant associa-
tion between response inhibition and instrumental activi-
ties of daily living [52]. Differences in the population
studied may be a potential reason for our conflicting find-
ing. Participants of the Brain POWER [21] cohort were
high functioning individuals. Hence, a ceiling effect for
both instrumental activities of daily living and health
related quality of life as assessed by the EQ-5D may have
existed. Further research is needed to better understand
the contribution of response inhibition to health related
quality of life.
Contrasting the imputed and complete case analyses
The lack of a significant association between global cog-
nition and HRQL for our complete case analysis was con-
trary to the results of our imputed data set analysis. This
difference likely was due to the smaller sample size of the
complete case analysis. A previous study found a linear
relationship between HRQL, assessed using the Assess-
ment of Quality of Life instrument, and MMSE in indi-
viduals with Alzheimer's disease -- a finding similar to
that of our imputed data set analysis [53]. Further, the
"absence of evidence is not evidence of absence [54]."
Bland and Altman highlighted study findings that are sta-
tistically nonsignificant is not an indication that these
findings are indeed nonsignificant or not of clinical
important. Rather, because studies lack the necessary
power to detect real, and clinically worthwhile, differ-
ences in treatment, that we should not interpret or con-
clude that this is necessarily evidence of no effect.
Therefore, because our findings are consistent with one
previous study [53], we interpret the discrepant results as
a lack of statically power to detect a difference given the
smaller sample size in our complete case analysis.
Timed Up and Go was a key explanatory variable in our 
model
We found that the TUG [34] was most strongly associ-
ated with HRQL in our bivariate analyses, accounting for
27% of the variation in QALYs. One previous study found
that functional ability/pain explained most of the varia-
tion in global utility score; however, this assessment was
not based on a specific measure of mobility such at the
TUG [55]. Three previous studies investigated the associ-
ation between the TUG and the Physical Function
domain of the SF-36 [56-58] and two indicated the TUG
explained approximately 20% of the variation [57,58].
Therefore, our findings extend previous work with a dif-
ference preference based generic utility instrument dem-
onstrating that TUG is strongly associated with EQ-5D
HSUVs.
Conclusions
We note that our small study sample consisted only of
older community dwelling women who were cognitively
intact; therefore, we cannot say with certainty that these
findings are generalizable to older women with mild cog-
nitive impairment or dementia, older men, other age
groups and adults who are not community-dwelling.
Thus, our study highlights the need for future prospec-
tive studies to ascertain whether our present finding
apply to other clinical populations and whether changes
in executive functions, specifically the cognitive pro-
cesses of set shifting and working memory are causally
linked to changes in HRQL assessed using generic prefer-
ence based HSUV instruments, such as the EQ-5D. Our
findings indicate that EQ-5D HSUV s over time can be
largely explained by baseline measures of age, waist girth,
functional comorbidity index, general mobility, global
cognition and the cognitive processes of set shifting and
working memory. Given that set shifting and working
memory explain a statistically significant amount of vari-
ability in QALYs, clinicians may need to consider assess-
ing these cognitive processes in response to patients
perceived health status (i.e., health related quality of life).
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